Comparison of FTD SARS-CoV-2 Assay and RealStar RT-PCR kit 1.0 for the detection of SARS-CoV-2

The aim of the study was to evaluate the clinical performance of FTD SARS-CoV-2 compared to the RealStar RT-PCR kit 1.0. The analysis of 100 nasopharyngeal swabs showed an overall agreement of 88 %. The positive percentage agreement was 85.6 % and the negative percentage agreement was 91 %. In concl...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Carlo, Daniele, Mazzuti, Laura, Sciandra, Ilaria, Guerrizio, Giuliana, Oliveto, Giuseppe, Riveros Cabral, Rodolfo J., Zingaropoli, Maria Antonella, Turriziani, Ombretta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420089/
https://www.ncbi.nlm.nih.gov/pubmed/34499965
http://dx.doi.org/10.1016/j.jviromet.2021.114276
Descripción
Sumario:The aim of the study was to evaluate the clinical performance of FTD SARS-CoV-2 compared to the RealStar RT-PCR kit 1.0. The analysis of 100 nasopharyngeal swabs showed an overall agreement of 88 %. The positive percentage agreement was 85.6 % and the negative percentage agreement was 91 %. In conclusion we observed a substantial agreement among the two methods, with discrepancies mainly observed in specimens with relatively low amount of viral RNA.

Ejemplares similares